Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives Francaises De Pediatrie|April 1, 1992
[Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol]D Girault, F Le Deist, M Debré, et al.
Blood|January 15, 1991
Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation reportA Fischer, W Friedrich, A Fasth, et al.
Bone Marrow Transplantation|June 1, 1994
Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantationJ Donadieu, J L Stephan, S Blanche, et al.
The Journal of Pediatrics|July 1, 1994
Intractable infant diarrhea associated with phenotypic abnormalities and immunodeficiencyD Girault, O Goulet, F Le Deist, et al.
Bone Marrow Transplantation|July 1, 1993
Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)J M Boiron, G Marit, C Fabéres, et al.
Clinical Transplantation|March 27, 2001
Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patientsJ M Kovarik, M D Pescovitz, H W Sollinger, et al.
Transplantation|January 9, 1998
Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allograftsJ Kovarik, P Wolf, J M Cisterne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myelomaP Moreau, D Fiere, W R Bezwoda, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Transplantation|October 17, 2001
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipientsC Ponticelli, A Yussim, V Cambi, et al.
Pageof 3